{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T04:51:55Z","timestamp":1781499115853,"version":"3.54.1"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2014,10,16]],"date-time":"2014-10-16T00:00:00Z","timestamp":1413417600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1186\/s12879-014-0543-y","type":"journal-article","created":{"date-parts":[[2014,10,15]],"date-time":"2014-10-15T11:01:31Z","timestamp":1413370891000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Persistent Lyme Empiric Antibiotic Study Europe (PLEASE) - design of a randomized controlled trial of prolonged antibiotic treatment in patients with persistent symptoms attributed to Lyme borreliosis"],"prefix":"10.1186","volume":"14","author":[{"given":"Anneleen","family":"Berende","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hadewych JM","family":"ter Hofstede","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A Rogier T","family":"Donders","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henri\u00ebt","family":"van Middendorp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roy PC","family":"Kessels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eddy MM","family":"Adang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fidel J","family":"Vos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea WM","family":"Evers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bart Jan","family":"Kullberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,10,16]]},"reference":[{"key":"543_CR1","first-page":"1","volume":"57","author":"RM Bacon","year":"2008","unstructured":"Bacon RM, Kugeler KJ, Mead PS: Surveillance for Lyme disease-United States, 1992-2006. MMWR Surveill Summ. 2008, 57: 1-9.","journal-title":"MMWR Surveill Summ"},{"key":"543_CR2","unstructured":"CDC Lyme Disease Statistics., [ http:\/\/www.cdc.gov\/lyme\/stats\/ ]"},{"key":"543_CR3","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1586\/eri.09.118","volume":"8","author":"P Heyman","year":"2010","unstructured":"Heyman P, Cochez C, Hofhuis A, van der Giessen J, Sprong H, Porter SR, Losson B, Saegerman C, Donoso-Mantke O, Niedrig M, Papa A: A clear and present danger: tick-borne diseases in Europe. Expert Rev Anti Infect Ther. 2010, 8: 33-50. 10.1586\/eri.09.118.","journal-title":"Expert Rev Anti Infect Ther"},{"key":"543_CR4","first-page":"84","volume":"21","author":"A Hofhuis","year":"2010","unstructured":"Hofhuis A, Harms MG, van der Giessen JWB, Sprong H, Notermans DW, van Pelt W: Ziekte van Lyme in Nederland 1994-2009: Aantal huisartsconsulten blijft toenemen. Is voorlichting en curatief beleid genoeg?. Infectieziekten Bull. 2010, 21: 84-87.","journal-title":"Infectieziekten Bull"},{"key":"543_CR5","first-page":"E060622","volume":"11","author":"A Hofhuis","year":"2006","unstructured":"Hofhuis A, van der Giessen JW, Borgsteede FH, Wielinga PR, Notermans DW, van Pelt W: Lyme borreliosis in the Netherlands: strong increase in GP consultations and hospital admissions in past 10 years. Euro Surveill. 2006, 11: E060622-060622.","journal-title":"Euro Surveill"},{"key":"543_CR6","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/S0025-7125(03)00090-7","volume":"86","author":"ST Donta","year":"2002","unstructured":"Donta ST: Late and chronic Lyme disease. Med Clin North Am. 2002, 86: 341-349. 10.1016\/S0025-7125(03)00090-7. vii","journal-title":"Med Clin North Am"},{"key":"543_CR7","doi-asserted-by":"publisher","first-page":"919","DOI":"10.7326\/0003-4819-131-12-199912210-00003","volume":"131","author":"NA Shadick","year":"1999","unstructured":"Shadick NA, Phillips CB, Sangha O, Logigian EL, Kaplan RF, Wright EA, Fossel AH, Fossel K, Berardi V, Lew RA, Liang MH: Musculoskeletal and neurologic outcomes in patients with previously treated Lyme disease. Ann Intern Med. 1999, 131: 919-926. 10.7326\/0003-4819-131-12-199912210-00003.","journal-title":"Ann Intern Med"},{"key":"543_CR8","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.1093\/ije\/dyi129","volume":"34","author":"V Cairns","year":"2005","unstructured":"Cairns V, Godwin J: Post-Lyme borreliosis syndrome: a meta-analysis of reported symptoms. Int J Epidemiol. 2005, 34: 1340-1345. 10.1093\/ije\/dyi129.","journal-title":"Int J Epidemiol"},{"key":"543_CR9","doi-asserted-by":"publisher","first-page":"697","DOI":"10.7326\/0003-4819-138-9-200305060-00005","volume":"138","author":"GP Wormser","year":"2003","unstructured":"Wormser GP, Ramanathan R, Nowakowski J, McKenna D, Holmgren D, Visintainer P, Dornbush R, Singh B, Nadelman RB: Duration of antibiotic therapy for early Lyme disease. A randomized, double-blind, placebo-controlled trial. Ann Intern Med. 2003, 138: 697-704. 10.7326\/0003-4819-138-9-200305060-00005.","journal-title":"Ann Intern Med"},{"key":"543_CR10","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1056\/NEJM200107123450202","volume":"345","author":"MS Klempner","year":"2001","unstructured":"Klempner MS, Hu LT, Evans J, Schmid CH, Johnson GM, Trevino RP, Norton D, Levy L, Wall D, McCall J, Kosinski M, Weinstein A: Two controlled trials of antibiotic treatment in patients with persistent symptoms and a history of Lyme disease. N Engl J Med. 2001, 345: 85-92. 10.1056\/NEJM200107123450202.","journal-title":"N Engl J Med"},{"key":"543_CR11","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1086\/508667","volume":"43","author":"GP Wormser","year":"2006","unstructured":"Wormser GP, Dattwyler RJ, Shapiro ED, Halperin JJ, Steere AC, Klempner MS, Krause PJ, Bakken JS, Strle F, Stanek G, Bockenstedt L, Fish D, Dumler JS, Nadelman RB: The clinical assessment, treatment, and prevention of lyme disease, human granulocytic anaplasmosis, and babesiosis: clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis. 2006, 43: 1089-1134. 10.1086\/508667.","journal-title":"Clin Infect Dis"},{"key":"543_CR12","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1093\/clind\/15.5.788","volume":"15","author":"HM Feder Jr","year":"1992","unstructured":"Feder HM, Gerber MA, Luger SW, Ryan RW: Persistence of serum antibodies to Borrelia burgdorferi in patients treated for Lyme disease. Clin Infect Dis. 1992, 15: 788-793. 10.1093\/clind\/15.5.788.","journal-title":"Clin Infect Dis"},{"key":"543_CR13","doi-asserted-by":"publisher","first-page":"473","DOI":"10.3109\/00365549609037943","volume":"28","author":"J Berglund","year":"1996","unstructured":"Berglund J, Eitrem R, Norrby SR: Long-term study of Lyme borreliosis in a highly endemic area in Sweden. Scand J Infect Dis. 1996, 28: 473-478. 10.3109\/00365549609037943.","journal-title":"Scand J Infect Dis"},{"key":"543_CR14","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/0163-4453(91)92936-Y","volume":"23","author":"H Kuiper","year":"1991","unstructured":"Kuiper H, de Jongh BM, Nauta AP, Houweling H, Wiessing LG, van Charante AW, Spanjaard L: Lyme borreliosis in Dutch forestry workers. J Infect. 1991, 23: 279-286. 10.1016\/0163-4453(91)92936-Y.","journal-title":"J Infect"},{"issue":"1","key":"543_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1086\/314053","volume":"31","author":"GP Wormser","year":"2000","unstructured":"Wormser GP, Nadelman RB, Dattwyler RJ, Dennis DT, Shapiro ED, Steere AC, Rush TJ, Rahn DW, Coyle PK, Persing DH, Fish D, Luft BJ: Practice guidelines for the treatment of Lyme disease. The Infectious Diseases Society of America. Clin Infect Dis. 2000, 31 (1): 1-14. 10.1086\/314053.","journal-title":"Clin Infect Dis"},{"key":"543_CR16","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1586\/14789072.2.1.S1","volume":"2","author":"D Cameron","year":"2004","unstructured":"Cameron D, Gaito A, Harris N, Bach G, Bellovin S, Bock K, Bock S, Burrascano J, Dickey C, Horowitz R, Phillips S, Meer-Scherrer L, Raxlen B, Sherr V, Smith H, Smith P, Stricker R, Group IW: Evidence-based guidelines for the management of Lyme disease. Expert Rev Anti Infect Ther. 2004, 2: S1-S13. 10.1586\/14789072.2.1.S1.","journal-title":"Expert Rev Anti Infect Ther"},{"key":"543_CR17","doi-asserted-by":"publisher","first-page":"1923","DOI":"10.1212\/01.WNL.0000071227.23769.9E","volume":"60","author":"LB Krupp","year":"2003","unstructured":"Krupp LB, Hyman LG, Grimson R, Coyle PK, Melville P, Ahnn S, Dattwyler R, Chandler B: Study and treatment of post Lyme disease (STOP-LD): a randomized double masked clinical trial. Neurology. 2003, 60: 1923-1930. 10.1212\/01.WNL.0000071227.23769.9E.","journal-title":"Neurology"},{"key":"543_CR18","first-page":"489","volume":"99","author":"D Cameron","year":"2008","unstructured":"Cameron D: Severity of Lyme disease with persistent symptoms. Insights from a double-blind placebo-controlled clinical trial. Minerva Med. 2008, 99: 489-496.","journal-title":"Minerva Med"},{"key":"543_CR19","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1016\/j.cct.2012.08.009","volume":"33","author":"AK Delong","year":"2012","unstructured":"Delong AK, Blossom B, Maloney EL, Phillips SE: Antibiotic retreatment of Lyme disease in patients with persistent symptoms: a biostatistical review of randomized, placebo-controlled, clinical trials. Contemp Clin Trials. 2012, 33: 1132-1142. 10.1016\/j.cct.2012.08.009.","journal-title":"Contemp Clin Trials"},{"key":"543_CR20","first-page":"741","volume":"108","author":"G Stanek","year":"1996","unstructured":"Stanek G, O'Connell S, Cimmino M, Aberer E, Kristoferitsch W, Granstrom M, Guy E, Gray J: European Union Concerted Action on Risk Assessment in Lyme Borreliosis: clinical case definitions for Lyme borreliosis. Wien Klin Wochenschr. 1996, 108: 741-747.","journal-title":"Wien Klin Wochenschr"},{"key":"543_CR21","doi-asserted-by":"crossref","first-page":"2241","DOI":"10.1128\/JCM.37.7.2241-2247.1999","volume":"37","author":"U Hauser","year":"1999","unstructured":"Hauser U, Lehnert G, Wilske B: Validity of interpretation criteria for standardized Western blots (immunoblots) for serodiagnosis of Lyme borreliosis based on sera collected throughout Europe. J Clin Microbiol. 1999, 37: 2241-2247.","journal-title":"J Clin Microbiol"},{"key":"543_CR22","volume-title":"Rand-36 Health Status Inventory","author":"RD Hays","year":"1998","unstructured":"Hays RD: Rand-36 Health Status Inventory. 1998, The Psychological Corporation, San Antonio"},{"key":"543_CR23","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1097\/00126334-200207010-00009","volume":"30","author":"PW Hugen","year":"2002","unstructured":"Hugen PW, Langebeek N, Burger DM, Zomer B, van Leusen R, Schuurman R, Koopmans PP, Hekster YA: Assessment of adherence to HIV protease inhibitors: comparison and combination of various methods, including MEMS (electronic monitoring), patient and nurse report, and therapeutic drug monitoring. J Acquir Immune Defic Syndr. 2002, 30: 324-334. 10.1097\/00126334-200207010-00009.","journal-title":"J Acquir Immune Defic Syndr"},{"key":"543_CR24","doi-asserted-by":"publisher","first-page":"345","DOI":"10.2165\/00003088-199732050-00001","volume":"32","author":"J Urquhart","year":"1997","unstructured":"Urquhart J: The electronic medication event monitor. Lessons for pharmacotherapy. Clin Pharmacokinet. 1997, 32: 345-356. 10.2165\/00003088-199732050-00001.","journal-title":"Clin Pharmacokinet"},{"key":"543_CR25","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1016\/S1474-4422(08)70119-4","volume":"7","author":"U Ljostad","year":"2008","unstructured":"Ljostad U, Skogvoll E, Eikeland R, Midgard R, Skarpaas T, Berg A, Mygland A: Oral doxycycline versus intravenous ceftriaxone for European Lyme neuroborreliosis: a multicentre, non-inferiority, double-blind, randomised trial. Lancet Neurol. 2008, 7: 690-695. 10.1016\/S1474-4422(08)70119-4.","journal-title":"Lancet Neurol"},{"key":"543_CR26","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/0022-3999(94)90099-X","volume":"38","author":"JH Vercoulen","year":"1994","unstructured":"Vercoulen JH, Swanink CM, Fennis JF, Galama JM, van der Meer JW, Bleijenberg G: Dimensional assessment of chronic fatigue syndrome. J Psychosom Res. 1994, 38: 383-392. 10.1016\/0022-3999(94)90099-X.","journal-title":"J Psychosom Res"},{"key":"543_CR27","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/S0304-3959(02)00274-9","volume":"100","author":"AW Evers","year":"2002","unstructured":"Evers AW, Kraaimaat FW, van Riel PL, de Jong AJ: Tailored cognitive-behavioral therapy in early rheumatoid arthritis for patients at risk: a randomized controlled trial. Pain. 2002, 100: 141-153. 10.1016\/S0304-3959(02)00274-9.","journal-title":"Pain"},{"key":"543_CR28","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1093\/rheumatology\/37.2.157","volume":"37","author":"AW Evers","year":"1998","unstructured":"Evers AW, Taal E, Kraaimaat FW, Jacobs JW, Abdel-Nasser A, Rasker JJ, Bijlsma JW: A comparison of two recently developed health status instruments for patients with arthritis: Dutch-AIMS2 and IRGL. Arthritis Impact Measurement Scales. Impact of Rheumatic diseases on General health and Lifestyle. Br J Rheumatol. 1998, 37: 157-164. 10.1093\/rheumatology\/37.2.157.","journal-title":"Br J Rheumatol"},{"key":"543_CR29","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1212\/01.WNL.0000284604.61160.2d","volume":"70","author":"BA Fallon","year":"2008","unstructured":"Fallon BA, Keilp JG, Corbera KM, Petkova E, Britton CB, Dwyer E, Slavov I, Cheng J, Dobkin J, Nelson DR, Sackeim HA: A randomized, placebo-controlled trial of repeated IV antibiotic therapy for Lyme encephalopathy. Neurology. 2008, 70: 992-1003. 10.1212\/01.WNL.0000284604.61160.2d.","journal-title":"Neurology"},{"key":"543_CR30","doi-asserted-by":"publisher","first-page":"1916","DOI":"10.1212\/01.WNL.0000068030.26992.25","volume":"60","author":"RF Kaplan","year":"2003","unstructured":"Kaplan RF, Trevino RP, Johnson GM, Levy L, Dornbush R, Hu LT, Evans J, Weinstein A, Schmid CH, Klempner MS: Cognitive function in post-treatment Lyme disease: do additional antibiotics help?. Neurology. 2003, 60: 1916-1922. 10.1212\/01.WNL.0000068030.26992.25.","journal-title":"Neurology"},{"key":"543_CR31","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1017\/S1355617705050344","volume":"11","author":"W Van der Elst","year":"2005","unstructured":"Van der Elst W, van Boxtel MP, van Breukelen GJ, Jolles J: Rey's verbal learning test: normative data for 1855 healthy participants aged 24-81 years and the influence of age, sex, education, and mode of presentation. J Int Neuropsychol Soc. 2005, 11: 290-302.","journal-title":"J Int Neuropsychol Soc"},{"key":"543_CR32","volume-title":"Wechsler Adult Intelligence Scale","author":"D Wechsler","year":"1997","unstructured":"Wechsler D: Wechsler Adult Intelligence Scale. 1997, Psychological Corporation, San Antonio, TX"},{"key":"543_CR33","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1017\/S1355617706060115","volume":"12","author":"W Van der Elst","year":"2006","unstructured":"Van der Elst W, Van Boxtel MP, Van Breukelen GJ, Jolles J: Normative data for the Animal, Profession and Letter M Naming verbal fluency tests for Dutch speaking participants and the effects of age, education, and sex. J Int Neuropsychol Soc. 2006, 12: 80-89.","journal-title":"J Int Neuropsychol Soc"},{"key":"543_CR34","doi-asserted-by":"publisher","first-page":"2277","DOI":"10.1038\/nprot.2006.390","volume":"1","author":"CR Bowie","year":"2006","unstructured":"Bowie CR, Harvey PD: Administration and interpretation of the Trail Making Test. Nat Protoc. 2006, 1: 2277-2281. 10.1038\/nprot.2006.390.","journal-title":"Nat Protoc"},{"key":"543_CR35","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1177\/1073191105283427","volume":"13","author":"W Van der Elst","year":"2006","unstructured":"Van der Elst W, Van Boxtel MP, Van Breukelen GJ, Jolles J: The Stroop color-word test: influence of age, sex, and education; and normative data for a large sample across the adult age range. Assessment. 2006, 13: 62-79. 10.1177\/1073191105283427.","journal-title":"Assessment"},{"key":"543_CR36","volume-title":"Manual of the Dutch adaption of the Wechsler Adult Intelligence Scale (WAIS) [Handleiding bij de Nederlandstalige bewerking van de Wechsler Adult Intelligence Scale (W.A.I.S.)]","author":"J Stinissen","year":"1970","unstructured":"Stinissen J, Willems P, Coetsier P, Hulsman WLL: Manual of the Dutch adaption of the Wechsler Adult Intelligence Scale (WAIS) [Handleiding bij de Nederlandstalige bewerking van de Wechsler Adult Intelligence Scale (W.A.I.S.)]. 1970, Swets & Zeitlinger, Lisse, the Netherlands"},{"key":"543_CR37","volume-title":"Neuropsychological assessment","author":"MD Lezak","year":"2012","unstructured":"Lezak MD, Howieson DB, Bigler ED, Tranel D: Neuropsychological assessment. 2012, Oxford University Press, New York"},{"key":"543_CR38","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1080\/01688639708403835","volume":"19","author":"S Schagen","year":"1997","unstructured":"Schagen S, Schmand B, de Sterke S, Lindeboom J: Amsterdam Short-Term Memory test: a new procedure for the detection of feigned memory deficits. J Clin Exp Neuropsychol. 1997, 19: 43-51. 10.1080\/01688639708403835.","journal-title":"J Clin Exp Neuropsychol"},{"key":"543_CR39","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1016\/S0022-3956(97)00039-3","volume":"31","author":"JH Vercoulen","year":"1997","unstructured":"Vercoulen JH, Bazelmans E, Swanink CM, Fennis JF, Galama JM, Jongen PJ, Hommes O, Van der Meer JW, Bleijenberg G: Physical activity in chronic fatigue syndrome: assessment and its role in fatigue. J Psychiatr Res. 1997, 31: 661-673. 10.1016\/S0022-3956(97)00039-3.","journal-title":"J Psychiatr Res"},{"key":"543_CR40","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/S0022-3999(00)00197-5","volume":"49","author":"SP van der Werf","year":"2000","unstructured":"van der Werf SP, Prins JB, Vercoulen JH, van der Meer JW, Bleijenberg G: Identifying physical activity patterns in chronic fatigue syndrome using actigraphic assessment. J Psychosom Res. 2000, 49: 373-379. 10.1016\/S0022-3999(00)00197-5.","journal-title":"J Psychosom Res"},{"key":"543_CR41","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1002\/hec.1124","volume":"15","author":"LM Lamers","year":"2006","unstructured":"Lamers LM, McDonnell J, Stalmeier PF, Krabbe PF, Busschbach JJ: The Dutch tariff: results and arguments for an effective design for national EQ-5D valuation studies. Health Econ. 2006, 15: 1121-1132. 10.1002\/hec.1124.","journal-title":"Health Econ"},{"key":"543_CR42","volume-title":"Handleiding Short Form- Health and Labour Questionnaire (SF-HLQ)","author":"L Hakkaart-van Roijen","year":"2010","unstructured":"Hakkaart-van Roijen L: Handleiding Short Form- Health and Labour Questionnaire (SF-HLQ). 2010, iMTA, Erasmus Universiteit, Rotterdam"},{"key":"543_CR43","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1017\/S0266462300009764","volume":"12","author":"L Van Roijen","year":"1996","unstructured":"Van Roijen L, Essink-Bot ML, Koopmanschap MA, Bonsel G, Rutten FF: Labor and health status in economic evaluation of health care. The Health and Labor Questionnaire. Int J Technol Assess Health Care. 1996, 12: 405-415. 10.1017\/S0266462300009764.","journal-title":"Int J Technol Assess Health Care"},{"key":"543_CR44","volume-title":"Manual for cost research: methods and unit costs for economic evaluations in health care [Handleiding voor kostenonderzoek: methoden en standaard kostprijzen voor economische evaluaties in de gezondheidszorg]","author":"L Hakkaart-van Roijen","year":"2010","unstructured":"Hakkaart-van Roijen L, Tan SS, Bouwmans CAM: Manual for cost research: methods and unit costs for economic evaluations in health care [Handleiding voor kostenonderzoek: methoden en standaard kostprijzen voor economische evaluaties in de gezondheidszorg]. 2010, College voor zorgverzekeringen, Diemen"},{"key":"543_CR45","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/0167-6296(94)00044-5","volume":"14","author":"MA Koopmanschap","year":"1995","unstructured":"Koopmanschap MA, Rutten FF, van Ineveld BM, van Roijen L: The friction cost method for measuring indirect costs of disease. J Health Econ. 1995, 14: 171-189. 10.1016\/0167-6296(94)00044-5.","journal-title":"J Health Econ"},{"key":"543_CR46","volume-title":"User's Manual for the SF-36v2 Health Survey","author":"ME Maruish","year":"2011","unstructured":"Maruish ME: User's Manual for the SF-36v2 Health Survey. 2011, QualityMetric Incorporated, Lincoln, RI"},{"key":"543_CR47","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1016\/j.jclinepi.2007.02.006","volume":"60","author":"GF Borm","year":"2007","unstructured":"Borm GF, Fransen J, Lemmens WA: A simple sample size formula for analysis of covariance in randomized clinical trials. J Clin Epidemiol. 2007, 60: 1234-1238. 10.1016\/j.jclinepi.2007.02.006.","journal-title":"J Clin Epidemiol"},{"key":"543_CR48","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1007\/s00508-005-0361-8","volume":"117","author":"RJ Dattwyler","year":"2005","unstructured":"Dattwyler RJ, Wormser GP, Rush TJ, Finkel MF, Schoen RT, Grunwaldt E, Franklin M, Hilton E, Bryant GL, Agger WA, Maladorno D: A comparison of two treatment regimens of ceftriaxone in late Lyme disease. Wien Klin Wochenschr. 2005, 117: 393-397. 10.1007\/s00508-005-0361-8.","journal-title":"Wien Klin Wochenschr"},{"key":"543_CR49","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1093\/clinids\/17.4.708","volume":"17","author":"AP Van Dam","year":"1993","unstructured":"Van Dam AP, Kuiper H, Vos K, Widjojokusumo A, de Jongh BM, Spanjaard L, Ramselaar AC, Kramer MD, Dankert J: Different genospecies of Borrelia burgdorferi are associated with distinct clinical manifestations of Lyme borreliosis. Clin Infect Dis. 1993, 17: 708-717. 10.1093\/clinids\/17.4.708.","journal-title":"Clin Infect Dis"},{"issue":"Suppl 1","key":"543_CR50","doi-asserted-by":"publisher","first-page":"S52","DOI":"10.1086\/516171","volume":"25","author":"ST Donta","year":"1997","unstructured":"Donta ST: Tetracycline therapy for chronic Lyme disease. Clin Infect Dis. 1997, 25 (Suppl 1): S52-S56. 10.1086\/516171.","journal-title":"Clin Infect Dis"},{"key":"543_CR51","first-page":"PI136","volume":"9","author":"ST Donta","year":"2003","unstructured":"Donta ST: Macrolide therapy of chronic Lyme Disease. Med Sci Monit. 2003, 9: PI136-PI142.","journal-title":"Med Sci Monit"},{"key":"543_CR52","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1093\/infdis\/166.5.1097","volume":"166","author":"M Maurin","year":"1992","unstructured":"Maurin M, Benoliel AM, Bongrand P, Raoult D: Phagolysosomal alkalinization and the bactericidal effect of antibiotics: the Coxiella burnetii paradigm. J Infect Dis. 1992, 166: 1097-1102. 10.1093\/infdis\/166.5.1097.","journal-title":"J Infect Dis"},{"key":"543_CR53","unstructured":"Burrascano J: Diagnostic Hints and Treatment Guidelines for Lyme and Other Tick Borne Illnesses., [ http:\/\/www.ilads.org\/lyme\/treatment-guideline.php ]"},{"key":"543_CR54","volume-title":"SF-36 Physical and Mental Health Summary Scales: a user's manual","author":"JEJ Ware","year":"1994","unstructured":"Ware JEJ, Kosinski M, Keller SD: SF-36 Physical and Mental Health Summary Scales: a user's manual. 1994, The Health Institute, New England Medical Center, Boston, MA"},{"key":"543_CR55","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1023\/A:1026191016380","volume":"12","author":"WE Cunningham","year":"2003","unstructured":"Cunningham WE, Nakazono TT, Tsai KL, Hays RD: Do differences in methods for constructing SF-36 physical and mental health summary measures change their associations with chronic medical conditions and utilization?. Qual Life Res. 2003, 12: 1029-1035. 10.1023\/A:1026191016380.","journal-title":"Qual Life Res"},{"key":"543_CR56","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1186\/1477-7525-5-54","volume":"5","author":"SS Farivar","year":"2007","unstructured":"Farivar SS, Cunningham WE, Hays RD: Correlated physical and mental health summary scores for the SF-36 and SF-12 Health Survey, V.I. Health Qual Life Outcomes. 2007, 5: 54-10.1186\/1477-7525-5-54.","journal-title":"Health Qual Life Outcomes"},{"key":"543_CR57","doi-asserted-by":"publisher","first-page":"350","DOI":"10.3109\/07853890109002089","volume":"33","author":"RD Hays","year":"2001","unstructured":"Hays RD, Morales LS: The RAND-36 measure of health-related quality of life. Ann Med. 2001, 33: 350-357. 10.3109\/07853890109002089.","journal-title":"Ann Med"},{"key":"543_CR58","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1097\/00005650-200010000-00006","volume":"38","author":"MW Nortvedt","year":"2000","unstructured":"Nortvedt MW, Riise T, Myhr KM, Nyland HI: Performance of the SF-36, SF-12, and RAND-36 summary scales in a multiple sclerosis population. Med Care. 2000, 38: 1022-1028. 10.1097\/00005650-200010000-00006.","journal-title":"Med Care"},{"key":"543_CR59","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.jclinepi.2006.04.003","volume":"60","author":"N Schmitz","year":"2007","unstructured":"Schmitz N, Kruse J: The SF-36 summary scores and their relation to mental disorders: physical functioning may affect performance of the summary scores. J Clin Epidemiol. 2007, 60: 163-170. 10.1016\/j.jclinepi.2006.04.003.","journal-title":"J Clin Epidemiol"},{"key":"543_CR60","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1097\/00005650-199804000-00012","volume":"36","author":"GE Simon","year":"1998","unstructured":"Simon GE, Revicki DA, Grothaus L, Vonkorff M: SF-36 summary scores: are physical and mental health truly distinct?. Med Care. 1998, 36: 567-572. 10.1097\/00005650-199804000-00012.","journal-title":"Med Care"},{"key":"543_CR61","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1023\/A:1012552211996","volume":"10","author":"C Taft","year":"2001","unstructured":"Taft C, Karlsson J, Sullivan M: Do SF-36 summary component scores accurately summarize subscale scores?. Qual Life Res. 2001, 10: 395-404. 10.1023\/A:1012552211996.","journal-title":"Qual Life Res"},{"key":"543_CR62","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1007\/BF01591686","volume":"45","author":"D Wilson","year":"2000","unstructured":"Wilson D, Parsons J, Tucker G: The SF-36 summary scales: problems and solutions. Soz Praventivmed. 2000, 45: 239-246. 10.1007\/BF01591686.","journal-title":"Soz Praventivmed"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12879-014-0543-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-014-0543-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-014-0543-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-014-0543-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,25]],"date-time":"2020-08-25T20:52:29Z","timestamp":1598388749000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-014-0543-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,10,16]]},"references-count":62,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["543"],"URL":"https:\/\/doi.org\/10.1186\/s12879-014-0543-y","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,10,16]]},"assertion":[{"value":"29 August 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 October 2014","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 October 2014","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"543"}}